COMP SERVICES (CMPS), Mind Cure Health (MCURF) - Psyched: Atai Raises $157M, Silo Wellness Goes Public, Mydecine Completes Export Of 'Magic Mushrooms'
Psychedelics and mental health company The Series D funding round is being touted as the psychedelics sector’s largest to date. Christian Angermayer, who founded Atai in 2018, led the effort with Thiel Capital, the venture capital firm of tech billionaire Peter Thiel. Apeiron Investment Group and Woodline Partners LP also participated. Atai’s portfolio companies are researching 13 different psychedelic and non-psychedelic compounds for the treatment of a wide range of mental health disorders. Atai is an early investor and holds a significant stake in Compass Pathways (NASDAQ: CMPS). La...